MarketCap
Varex Imaging Corporation VREX
$ 18.45
0.08%
Facebook
X
Telegram
Varex Imaging Corporation Operating Income | VREX
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Varex Imaging Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -27.8 M | 32.1 M | 77.1 M | 88.2 M | 74.1 M | -33.7 M | 45.7 M | 44.5 M | 83.7 M | 109 M | 128 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 128 M | -33.7 M | 56.4 M |
Quarterly Operating Income Varex Imaging Corporation
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -80.7 M | 14.4 M | 15.4 M | 15.4 M | - | -80.7 M | 22.1 M | 11.2 M | - | 9.3 M | 7.7 M | 4.2 M | - | 24.2 M | 15.6 M | 13 M | - | 23 M | 26.6 M | 14 M | - | 25.7 M | 15.8 M | 4.6 M | -20.8 M | -26.8 M | 1.4 M | - | 29.5 M | 4.6 M | 14.5 M | 10.4 M | 38.1 M | 7.3 M | 10.4 M | 13.6 M | 57.1 M | 15.5 M | 13.6 M | 18.6 M | 76.1 M | 28.4 M | 18.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 76.1 M | -80.7 M | 11.1 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M |  USA |
 |
Boston Scientific Corporation
BSX
|
3.61 B | $ 43.92 | 0.06 % | $ 65 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
13.3 M | $ 8.52 | 0.06 % | $ 621 M |  Israel |
 |
ClearPoint Neuro
CLPT
|
-24.2 M | $ 14.83 | 1.51 % | $ 420 M | USA |
 |
CONMED Corporation
CNMD
|
103 M | $ 45.38 | 0.44 % | $ 1.41 B | USA |
 |
Cytosorbents Corporation
CTSO
|
-14.7 M | $ 4.38 | 1.86 % | $ 273 M | USA |
 |
Delcath Systems
DCTH
|
660 K | $ 15.6 | 0.75 % | $ 559 M | USA |
 |
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | USA |
 |
Medigus Ltd.
MDGS
|
-9.9 M | - | 10.28 % | $ 55.5 M | Israel |
 |
Electromed
ELMD
|
13.9 M | $ 27.88 | 0.07 % | $ 230 M | USA |
 |
Cutera
CUTR
|
-156 M | - | -10.19 % | $ 1.99 M | USA |
 |
Establishment Labs Holdings
ESTA
|
-39 M | $ 65.97 | 0.59 % | $ 1.95 B |  Costa-rica |
 |
Edwards Lifesciences Corporation
EW
|
1.26 B | $ 86.29 | 0.66 % | $ 50.5 B | USA |
 |
Nemaura Medical
NMRD
|
-9.6 M | - | -17.8 % | $ 2.74 M |  Britain |
 |
Helius Medical Technologies
HSDT
|
-244 M | $ 2.94 | 1.38 % | $ 64.8 M | USA |
 |
AdaptHealth Corp.
AHCO
|
90.9 M | $ 5.64 | 1.26 % | $ 762 M | USA |
 |
Inogen
INGN
|
-30.2 M | $ 5.36 | 2.49 % | $ 143 M | USA |
 |
InMode Ltd.
INMD
|
85.4 M | $ 14.26 | 0.49 % | $ 922 M | Israel |
 |
Inspire Medical Systems
INSP
|
51 M | $ 70.5 | 2.46 % | $ 2.07 B | USA |
 |
IRIDEX Corporation
IRIX
|
-2.57 M | $ 0.63 | 0.16 % | $ 10.7 M | USA |
 |
IRadimed Corporation
IRMD
|
26.1 M | $ 85.76 | 0.66 % | $ 1.09 B | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
AxoGen
AXGN
|
-7.85 M | $ 43.39 | 0.16 % | $ 2 B | USA |
 |
Align Technology
ALGN
|
546 M | $ 146.78 | 0.79 % | $ 10.6 B | USA |
|
LENSAR
LNSR
|
-24.6 M | $ 6.92 | 0.28 % | $ 82.7 M | USA |
 |
Sientra
SIEN
|
-69 M | - | -16.59 % | $ 10.3 M | USA |
 |
Silk Road Medical, Inc
SILK
|
-59.3 M | - | - | $ 1.07 B | USA |
 |
Medtronic PLC
MDT
|
6.47 B | $ 88.64 | 0.98 % | $ 114 B | USA |
 |
MiMedx Group
MDXG
|
63.9 M | $ 4.67 | 0.1 % | $ 690 M | USA |
 |
Surgalign Holdings
SRGA
|
-78.5 M | - | -32.98 % | $ 1.68 M | USA |
 |
ShockWave Medical
SWAV
|
159 M | - | - | $ 12.3 B | USA |
 |
Myomo
MYO
|
-14.4 M | $ 1.61 | 0.6 % | $ 67.4 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-78.2 M | $ 0.64 | 0.02 % | $ 41.5 M | Israel |
 |
InspireMD
NSPR
|
-49.6 M | $ 0.7 | 0.71 % | $ 45 M | Israel |
 |
Orthofix Medical
OFIX
|
-81.4 M | $ 9.44 | 3.06 % | $ 374 M |  Curacao |
 |
Outset Medical
OM
|
-66.7 M | $ 3.05 | 1.29 % | $ 46.4 K | USA |
 |
Insulet Corporation
PODD
|
474 M | $ 136.13 | 0.26 % | $ 9.58 B | USA |
 |
Quanterix Corporation
QTRX
|
-126 M | $ 3.27 | 2.83 % | $ 139 M | USA |
 |
Titan Medical
TMDI
|
-31 M | - | -26.32 % | $ 19.6 M | Canada |
 |
AVITA Medical
RCEL
|
-42.5 M | $ 11.84 | 2.25 % | $ 330 M |  Australia |
 |
Natus Medical Incorporated
NTUS
|
23.8 M | - | 1.94 % | $ 1.05 B | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
Apyx Medical Corporation
APYX
|
-6.45 M | $ 2.96 | 4.59 % | $ 122 M | USA |
 |
Sintx Technologies
SINT
|
-10.7 M | $ 1.88 | 0.53 % | $ 5.21 M | USA |
 |
Smith & Nephew plc
SNN
|
794 M | $ 26.91 | 0.86 % | $ 23.3 B | Britain |
 |
Accuray Incorporated
ARAY
|
-26.4 M | $ 0.22 | 1.84 % | $ 27 M | USA |
 |
Inari Medical
NARI
|
-14 M | - | - | $ 4.23 B | USA |
 |
Sensus Healthcare
SRTS
|
-10.3 M | $ 2.94 | 1.03 % | $ 48 M | USA |
 |
Bruker Corporation
BRKR
|
68.2 M | $ 64.18 | 0.28 % | $ 9.74 B | USA |
 |
Stryker Corporation
SYK
|
4.89 B | $ 272.36 | 0.97 % | $ 104 B | USA |